Even if SRX is now at fair value now on current indications, you get the free option of the upcoming trial results which would likely double dosage rates within 3 years if successful.
The trials were many years in the making and now only 6 months or so away. This is the time to be holding.
I agree, the investor community will see the glass as half full next week.
Add to My Watchlist
What is My Watchlist?